104 related articles for article (PubMed ID: 27567094)
1. Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta.
Lai FY; Dover DC; Charlton CL
J Clin Virol; 2016 Oct; 83():43-7. PubMed ID: 27567094
[TBL] [Abstract][Full Text] [Related]
2. Determining rubella immunity in pregnant Alberta women 2009-2012.
Lai FY; Dover DC; Lee B; Fonseca K; Solomon N; Plitt SS; Jaipaul J; Tipples GA; Charlton CL
Vaccine; 2015 Jan; 33(5):635-41. PubMed ID: 25533327
[TBL] [Abstract][Full Text] [Related]
3. Determination of rubella virus-specific humoral and cell-mediated immunity in pregnant women with negative or equivocal rubella-specific IgG in routine screening.
Picone O; Bouthry E; Bejaoui-Olhmann Y; Cordier AG; Nedellec S; Letourneau A; Carbonel M; Brollo M; Grangeot-Keros L; Ayoubi JM; Benachi A; Rouge E; Vauloup-Fellous C
J Clin Virol; 2019 Mar; 112():27-33. PubMed ID: 30711798
[TBL] [Abstract][Full Text] [Related]
4. How to determine protective immunity in the post-vaccine era.
Charlton CL; Lai FY; Dover DC
Hum Vaccin Immunother; 2016 Apr; 12(4):903-6. PubMed ID: 26811063
[TBL] [Abstract][Full Text] [Related]
5. Performance of 14 rubella IgG immunoassays on samples with low positive or negative haemagglutination inhibition results.
Huzly D; Hanselmann I; Neumann-Haefelin D; Panning M
J Clin Virol; 2016 Jan; 74():13-8. PubMed ID: 26638144
[TBL] [Abstract][Full Text] [Related]
6. Universal rubella vaccination programme and maternal rubella immune status: a tale of two systems.
Lao TT; Suen SSH; Leung TY; Sahota DS; Lau TK
Vaccine; 2010 Mar; 28(10):2227-2230. PubMed ID: 20060083
[TBL] [Abstract][Full Text] [Related]
7. Performance of the Elecsys Rubella IgG assay in the diagnostic laboratory setting for assessment of immune status.
Enders M; Bartelt U; Knotek F; Bunn K; Strobel S; Dietz K; Enders G
Clin Vaccine Immunol; 2013 Mar; 20(3):420-6. PubMed ID: 23345585
[TBL] [Abstract][Full Text] [Related]
8. Rubella antibodies in normal pregnant women at Srinagarind Hospital, Khon Kaen, Thailand.
Boonruang S; Buppasiri P
J Med Assoc Thai; 2005 Apr; 88(4):455-9. PubMed ID: 16146247
[TBL] [Abstract][Full Text] [Related]
9. An audit of rubella IgG antibody status in antenatal women in a NHS Trust over 5 years (2005-2009).
Matthews LA; Lawrance LM; Gray D; Gray S
Epidemiol Infect; 2011 Nov; 139(11):1720-6. PubMed ID: 21138620
[TBL] [Abstract][Full Text] [Related]
10. Immune status of health care personnel & post vaccination analysis of immunity against rubella in an eye hospital.
Rajasundari TA; Chandrasekar K; Vijayalakshmi P; Muthukkaruppan V
Indian J Med Res; 2006 Nov; 124(5):553-8. PubMed ID: 17213524
[TBL] [Abstract][Full Text] [Related]
11. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey.
Seker S; Abasiyanik MF; Salih BA
Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria.
Onakewhor JU; Chiwuzie J
Niger J Clin Pract; 2011; 14(2):140-5. PubMed ID: 21860127
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes.
Kakoulidou M; Forsgren M; Lewensohn-Fuchs I; Johansen K
Vaccine; 2010 Jan; 28(4):1002-7. PubMed ID: 19925909
[TBL] [Abstract][Full Text] [Related]
14. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data.
Artimos de Oliveira S; Bastos Camacho LA; Uzeda Barreto MC; Coca Velarde LG; Siqueira MM
J Infect Dis; 2011 Sep; 204 Suppl 2():S664-8. PubMed ID: 21954264
[TBL] [Abstract][Full Text] [Related]
15. The economic impact of prenatal varicella immunity among pregnant women in Alberta.
Passi A; Plitt SS; Lai FY; Simmonds K; Charlton CL
Vaccine; 2017 Jan; 35(4):570-576. PubMed ID: 28017427
[TBL] [Abstract][Full Text] [Related]
16. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
Okafuji T; Okafuji T; Nakayama T
Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013.
Plans P; de Ory F; Campins M; Álvarez E; Payà T; Guisasola E; Compte C; Vellbé K; Sánchez C; Lozano MJ; Aran I; Bonmatí A; Carreras R; Jané M; Cabero L
Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1161-71. PubMed ID: 25666082
[TBL] [Abstract][Full Text] [Related]
18. Rubella seronegativity in antenatal screening - Is it influenced by the introduction of universal childhood rubella immunization?
Lao TT; Sahota DS; Law LW; Leung TY
Vaccine; 2015 Sep; 33(38):4776-81. PubMed ID: 26271826
[TBL] [Abstract][Full Text] [Related]
19. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
